Oruka Therapeutics, Inc.
ORKA • XNAS
Oruka Therapeutics, Inc. is a in vitro & in vivo diagnostic substances company trading on XNAS, led by CEO Lawrence Otto Klein, with a market cap of $3.5B.
Market Cap$3.5B
CEOLawrence Otto Klein
CountryUnited States of America
IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
Next EarningsMay 13, 2026 · In 2 weeksBefore Market Open · Q1 2026
Financials
Oruka Therapeutics, Inc. FAQ
Common questions about Oruka Therapeutics, Inc.
Oruka Therapeutics, Inc. is scheduled to report earnings for Q1 2026 on May 13, 2026 before market open.